HYDROmorphone Injectable Syringes Recalled Over Sterility Assurance Issues
Central Admixture Pharmacy Services is recalling 1,190 units of HYDROmorphone injectable syringes nationwide due to lack of sterility assurance. Patients using affected lots should contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of an injectable medication with sterility assurance deficiency. While no illnesses or injuries have been reported, this constitutes a risk-of-harm situation for a critical-use injectable product where sterility is essential.
Plain-English summary
Central Admixture Pharmacy Services Inc. is recalling HYDROmorphone in 0.9% sodium chloride injectable syringes (10 mg/50 mL) distributed nationwide. The recall affects 1,190 units across multiple lots with expiration dates in October 2023.
The manufacturer has determined that these syringes cannot be assured to meet sterility requirements. Sterility is a critical safety attribute for injectable medications, and any deficiency in sterility assurance poses a potential risk to patients.
Patients who have received syringes from the affected lots should contact their healthcare provider or pharmacy immediately. Healthcare facilities should identify patients who may have received affected product and take appropriate action.
The recalled product
- Product
- HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Category
- Drug — Prescription Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot:17-275728
- Exp. 10/9/2023
- 17-275791
- 17-275803
- Exp. 10/10/2023
- 17-276244
- Exp. 10/20/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 32 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29